Thong-Gyu Jin,Yo Kyung Chung,Sang Hoon Paik,Yoo Chang Park,Jinwook Seo,Yong Woon Choi,Jong Mun Son,Yong-Chul Kim
申请号：
US14809856
公开号：
US09249397B2
申请日:
2015.07.27
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Disclosed are a composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for treating Hunter syndrome. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
